PaxMedica Inc (PXMD)
0.3302
-0.03
(-8.28%)
USD |
OTCM |
May 31, 16:00
PaxMedica Enterprise Value: 0.942M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.942M |
| May 30, 2024 | 1.174M |
| May 29, 2024 | 0.8782M |
| May 28, 2024 | 1.018M |
| May 24, 2024 | 0.8098M |
| May 23, 2024 | 0.5126M |
| May 22, 2024 | 0.7071M |
| May 21, 2024 | 0.6822M |
| May 20, 2024 | 0.1152M |
| May 17, 2024 | 0.2411M |
| May 16, 2024 | 0.2695M |
| May 15, 2024 | 0.4231M |
| May 14, 2024 | -0.0164M |
| May 13, 2024 | 0.1532M |
| May 10, 2024 | -0.0815M |
| May 09, 2024 | 0.1559M |
| May 08, 2024 | -0.0591M |
| May 07, 2024 | 0.2619M |
| May 06, 2024 | 0.4262M |
| May 03, 2024 | 0.7397M |
| May 02, 2024 | 1.135M |
| May 01, 2024 | 3.512M |
| April 30, 2024 | 3.935M |
| April 29, 2024 | 3.905M |
| April 26, 2024 | 3.896M |
| Date | Value |
|---|---|
| April 25, 2024 | 3.630M |
| April 24, 2024 | 3.539M |
| April 23, 2024 | 3.718M |
| April 22, 2024 | 3.990M |
| April 19, 2024 | 4.054M |
| April 18, 2024 | 4.070M |
| April 17, 2024 | 4.345M |
| April 16, 2024 | 3.300M |
| April 15, 2024 | 3.898M |
| April 12, 2024 | 4.637M |
| April 11, 2024 | 1.448M |
| April 10, 2024 | 1.583M |
| April 09, 2024 | 1.789M |
| April 08, 2024 | 1.889M |
| April 05, 2024 | 2.031M |
| April 04, 2024 | 1.942M |
| April 03, 2024 | 2.397M |
| April 02, 2024 | 2.330M |
| April 01, 2024 | 2.472M |
| March 28, 2024 | -0.9032M |
| March 27, 2024 | -0.7165M |
| March 26, 2024 | -0.8972M |
| March 25, 2024 | -0.4254M |
| March 22, 2024 | -0.5911M |
| March 21, 2024 | -0.1193M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.676M
Minimum
Feb 08 2024
52.98M
Maximum
Sep 02 2022
13.06M
Average
9.615M
Median
Jul 26 2023
Enterprise Value Benchmarks
| Agenus Inc | 301.30M |
| Adial Pharmaceuticals Inc | 1.071M |
| Rallybio Corp | -24.54M |
| Nutex Health Inc | 59.02M |
| Monogram Technologies Inc | 52.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.693M |
| Total Expenses (Quarterly) | 3.690M |
| EPS Diluted (Quarterly) | -8.50 |
| Earnings Yield | -5.63K% |